| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |